Customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology.
Request for report sample at@ https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample
The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected to observe faster growth in demand, witnessing a CAGR of 6.8% during the forecast period. This growth can be attributed to the high usage of a wide range of reagents including substrates, additives, buffers, precipitation agents, and others for the purpose of peptide synthesis.
Among the various applications, commercial application is the fastest growing category in the customized peptide synthesis industry, demonstrating a CAGR of 6.9% during the forecast period. The recent advancements in chemical peptide synthesis and inclusion of modified amino acids have increased the commercial potential of customized peptides.
During the forecast period, customized peptide synthesis market in APAC is expected to witness the fastest growth, observing a CAGR of 7.9%. The growth in the market is mainly led by the increasing use of peptides in drug discovery, low cost of raw materials, technological advancements, increasing life sciences research activities, and availability of funds for research and development.
Browse report at@ https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market
Globally, the customized peptide synthesis market is witnessing rapid evolution with the development and launch of new peptide-based products. For instance, in September 2018, Biotage AB launched its new Alstra remote software, which enables the users to program the peptide synthesis setup offline, subsequently import peptide sequences, and then execute the synthesis on Initiator + Alstra.
Some of the other key players operating in the customized peptide synthesis industry are GenScript Biotech Corporation, Bachem AG, Thermo Fisher Scientific Inc., AAPPTec LLC, Advanced ChemTech, AnaSpec Inc., New England Peptide Inc., Rockland Immunochemicals Inc., INTAVIS Bioanalytical Instruments AG, and JPT Peptide Technologies GmbH.
About
P&S Intelligence
P&S
Intelligence is a provider of market research and consulting services catering
to the market information needs of burgeoning industries across the world.
Providing the plinth of market intelligence, P&S as an enterprising
research and consulting company, believes in providing thorough landscape
analyses on the ever-changing market scenario, to empower companies to make
informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886
(USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Connect with us: LinkedIn | Twitter | Facebook
0 Comments